ASX - By Stock
|
LPD |
Re:
Ann: Entitlement Offer Reminder
|
|
spaedi
|
58 |
16K |
11 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
58
|
16K
|
11
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Entitlement Offer Reminder
|
|
spaedi
|
58 |
16K |
19 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
58
|
16K
|
19
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
spaedi
|
18 |
6.2K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
6.2K
|
6
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
spaedi
|
18 |
6.2K |
12 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
18
|
6.2K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
spaedi
|
216 |
66K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
216
|
66K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
spaedi
|
32K |
15M |
8 |
22/04/24 |
22/04/24 |
Charts
|
32K
|
15M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
From the Professor...
|
|
spaedi
|
41 |
20K |
8 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
41
|
20K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
From the Professor...
|
|
spaedi
|
41 |
20K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
41
|
20K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
spaedi
|
144 |
63K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
63K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
spaedi
|
144 |
63K |
9 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
63K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
spaedi
|
144 |
63K |
17 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
63K
|
17
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Supplementary Prospectus
|
|
spaedi
|
54 |
17K |
10 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
54
|
17K
|
10
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Supplementary Prospectus
|
|
spaedi
|
54 |
17K |
12 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
54
|
17K
|
12
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Entitlement Issue Prospectus
|
|
spaedi
|
18 |
5.7K |
4 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
18
|
5.7K
|
4
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Renounceable Entitlements Offer to Fund Arrangement of Phase
|
|
spaedi
|
96 |
36K |
14 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
96
|
36K
|
14
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Renounceable Entitlements Offer to Fund Arrangement of Phase
|
|
spaedi
|
96 |
36K |
17 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
96
|
36K
|
17
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Trading Halt
|
|
spaedi
|
78 |
27K |
9 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
78
|
27K
|
9
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Trading Halt
|
|
spaedi
|
78 |
27K |
14 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
78
|
27K
|
14
|
|
ASX - By Stock
|
LPD |
Re:
General Discussion
|
|
spaedi
|
678 |
217K |
3 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
678
|
217K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
Ann: Continuation of Suspension from Quotation
|
|
spaedi
|
41 |
23K |
8 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
41
|
23K
|
8
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
spaedi
|
426 |
122K |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
426
|
122K
|
3
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
spaedi
|
426 |
122K |
6 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
426
|
122K
|
6
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
spaedi
|
174 |
76K |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
174
|
76K
|
7
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
spaedi
|
174 |
76K |
5 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
174
|
76K
|
5
|
|
ASX - By Stock
|
LPD |
Re:
General Discussion
|
|
spaedi
|
678 |
217K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
678
|
217K
|
8
|
|
ASX - By Stock
|
LPD |
Re:
General Discussion
|
|
spaedi
|
678 |
217K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
678
|
217K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Half Yearly Report and Accounts
|
|
spaedi
|
143 |
69K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
143
|
69K
|
5
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
spaedi
|
174 |
76K |
3 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
174
|
76K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
spaedi
|
174 |
76K |
4 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
174
|
76K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
spaedi
|
104 |
58K |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
104
|
58K
|
4
|
|
ASX - By Stock
|
BPH |
Re:
Ann: Trading Halt
|
|
spaedi
|
110 |
35K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
110
|
35K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
spaedi
|
77 |
37K |
2 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
77
|
37K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
spaedi
|
77 |
37K |
6 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
77
|
37K
|
6
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
spaedi
|
426 |
122K |
5 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
426
|
122K
|
5
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
spaedi
|
174 |
76K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
174
|
76K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
spaedi
|
177 |
78K |
4 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
177
|
78K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
spaedi
|
177 |
78K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
spaedi
|
177 |
78K |
3 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
3
|
|
ASX - By Stock
|
XTC |
Re:
good news
|
|
spaedi
|
174 |
76K |
2 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
174
|
76K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
spaedi
|
177 |
78K |
19 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
177
|
78K
|
19
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
spaedi
|
32K |
15M |
7 |
06/12/23 |
06/12/23 |
Charts
|
32K
|
15M
|
7
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: CEO Notice of Discharge
|
|
spaedi
|
4 |
1.5K |
0 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
spaedi
|
13K |
6.3M |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
spaedi
|
13K |
6.3M |
7 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|
ASX - By Stock
|
LPD |
Re:
Ann: AGM Presentation - November 2023
|
|
spaedi
|
3 |
2.1K |
12 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
3
|
2.1K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
spaedi
|
13K |
6.3M |
4 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
spaedi
|
315 |
145K |
8 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
145K
|
8
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Offer Accepted
|
|
spaedi
|
45 |
13K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
45
|
13K
|
0
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Offer Received
|
|
spaedi
|
39 |
10K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
39
|
10K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
spaedi
|
13K |
6.3M |
4 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|